Surrozen, Inc. (SRZN)
Surrozen, Inc., a biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair and regeneration. It is developing tissue-specific antibodies with application across various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, and central nervous system. Its products in pipeline include SZN-043 a tissue-specific R-spondin mimetic for the treatment of severe liver disease; and SZN-1326, a bi-specific full-length human antibody that directly modulates Wnt signaling in target tissue by binding to particular Frizzled and LRP receptors that are expressed in intestinal crypts. Surrozen, Inc. was founded in 2015 and is headquartered in South San Francisco, California.
$27.86M
Mr. Craig C. Parker M.B.A.
83.00
South San Francisco, CA
Aug 09, 2021
-0.39
$-22.49
5.66
8.93
-248.94%
-0.39
0.22
0.98
8.58
-48.62%
-45.83%
Similar stocks (19)
Keros Therapeutics, Inc.
KROS
Replimune Group, Inc.
REPL
Larimar Therapeutics, Inc.
LRMR
Instil Bio, Inc.
TIL
Gossamer Bio, Inc.
GOSS
Nuvectis Pharma, Inc.
NVCT
Assembly Biosciences, Inc.
ASMB
CytomX Therapeutics, Inc.
CTMX
Armata Pharmaceuticals, Inc.
ARMP
Spero Therapeutics, Inc.
SPRO
Kronos Bio, Inc.
KRON
Kezar Life Sciences, Inc.
KZR
Unicycive Therapeutics, Inc.
UNCY
Tempest Therapeutics, Inc.
TPST
Bolt Biotherapeutics, Inc.
BOLT
Lyra Therapeutics, Inc.
LYRA
Processa Pharmaceuticals, Inc.
PCSA
NexImmune, Inc.
NEXI
Evelo Biosciences, Inc.
EVLO
ETF Exposure (7)
iShares Micro-Cap ETF
IWC
0.00594%
Dimensional U.S. Targeted Value ETF
DFAT
2.698e-5%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%
Similar stocks (19)
Keros Therapeutics, Inc.
KROS
Replimune Group, Inc.
REPL
Larimar Therapeutics, Inc.
LRMR
Instil Bio, Inc.
TIL
Gossamer Bio, Inc.
GOSS
Nuvectis Pharma, Inc.
NVCT
Assembly Biosciences, Inc.
ASMB
CytomX Therapeutics, Inc.
CTMX
Armata Pharmaceuticals, Inc.
ARMP
Spero Therapeutics, Inc.
SPRO
Kronos Bio, Inc.
KRON
Kezar Life Sciences, Inc.
KZR
Unicycive Therapeutics, Inc.
UNCY
Tempest Therapeutics, Inc.
TPST
Bolt Biotherapeutics, Inc.
BOLT
Lyra Therapeutics, Inc.
LYRA
Processa Pharmaceuticals, Inc.
PCSA
NexImmune, Inc.
NEXI
Evelo Biosciences, Inc.
EVLO
ETF Exposure (7)
iShares Micro-Cap ETF
IWC
0.00594%
Dimensional U.S. Targeted Value ETF
DFAT
2.698e-5%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%